title: [Severe thrombocytopenia and mild leucopenia associated with deferasirox therapy].
authors.forename: Aurélie
authors.initials: A
authors.lastname: Grandvuillemin
authors.forename: Sylvain
authors.initials: S
authors.lastname: Audia
authors.forename: Vanessa
authors.initials: V
authors.lastname: Leguy-Seguin
authors.forename: Valérie
authors.initials: V
authors.lastname: Coullet
authors.forename: Bernard
authors.initials: B
authors.lastname: Bonnotte
authors.forename: Catherine
authors.initials: C
authors.lastname: Sgro
mesh_terms: D000756:Anemia, Sideroblastic / Q000150:complications / Q000188:drug therapy; D001565:Benzoates / Q000009:adverse effects* / Q000627:therapeutic use; D002614:Chelating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000077588:Deferasirox; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D017713:Platelet Transfusion; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D001565:Benzoates; D002614:Chelating Agents; D014230:Triazoles; D000077588:Deferasirox